PharmaSynth as partner

We work with partners to drive progress in our organization, supply reliable products to the market and reach different geographical areas of the world. We strive, through our services, to have a positive impact on the diagnosis and treatment of today's most controversial diseases.

We offer high quality precursors for research and clinical use and our products cover several applications, from neuroscience to endocrine disorders.

We are always active in molecule development and we work together with our clients to perform custom synthesis, according to special requests.

We are a reliable partner and we act with integrity and responsibility to meet our customer's needs and deliver our promises.

Partners

Nard Insitute, Japan
Our partnership with NARD Institute, Japan, started in 2006.
Since then, we have been working together on the development of new products and distribution of PET/SPECT precursors that are for general use, as well as standard materials.
NARD Institute is official distributor of PharmaSynth products in Japan.

NARD Institute, Ltd. is a research contract company in the field of chemistry in Japan. The business domain of NARD Institute covers extensive fields of chemistry such as inorganic chemistry, organic chemistry, chemistry of naturally-occurring substances, polymer chemistry, life science-related chemistry, etc.

Academic collaborators

Tartu University, Estonia
Tartu University is our partner since 2006 and they add value to our products by performing quality control services. In addition to this, we have collaborated on development of new products.

Tartu University is Estonia's leading centre of research and training. According to information on the ISI Web of Science, the University of Tartu belongs to the top 1% of the world's most-cited universities and research institutions in the fields of Clinical Medicine, Chemistry, Environment/Ecology, Plant and Animal Science, Geosciences, Social Sciences (general), Biology and Biochemistry and Engineering.
Karolinska Institute, Sweden
Our cooperation with Karolinska Institute, Sweden, started in 2007 and it covers services of test-labeling for some of our products.

Karolinska Institutet is one of the world´s leading medical universities. It accounts for over 40 per cent of the medical academic research conducted in Sweden and offers the country´s broadest range of education in medicine and health sciences.
Contact
For further partnership information please contact Jukka Hiltunen at
jukka@pharmasynth.ee